Chicago Partners Investment Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478K | Buy |
884
+265
| +43% | +$143K | 0.01% | 622 |
|
|
2025
Q1 | $301K | Sell |
619
-44
| -7% | -$21.4K | 0.01% | 686 |
|
|
2024
Q4 | $287K | Sell |
663
-9
| -1% | -$3.89K | 0.01% | 678 |
|
|
2024
Q3 | $308K | Buy |
672
+96
| +17% | +$44K | 0.01% | 618 |
|
|
2024
Q2 | $273K | Sell |
576
-21
| -4% | -$9.96K | 0.01% | 617 |
|
|
2024
Q1 | $295K | Buy |
597
+6
| +1% | +$2.96K | 0.01% | 573 |
|
|
2023
Q4 | $307K | Sell |
591
-56
| -9% | -$29.1K | 0.01% | 536 |
|
|
2023
Q3 | $277K | Buy |
647
+19
| +3% | +$8.13K | 0.01% | 532 |
|
|
2023
Q2 | $326K | Sell |
628
-34
| -5% | -$17.7K | 0.02% | 510 |
|
|
2023
Q1 | $333K | Buy |
662
+2
| +0.3% | +$1.01K | 0.02% | 482 |
|
|
2022
Q4 | $335K | Buy |
660
+2
| +0.3% | +$1.02K | 0.02% | 457 |
|
|
2022
Q3 | $253K | Buy |
658
+68
| +12% | +$26.1K | 0.02% | 474 |
|
|
2022
Q2 | $236K | Sell |
590
-60
| -9% | -$24K | 0.02% | 498 |
|
|
2022
Q1 | $232K | Buy |
650
+46
| +8% | +$16.4K | 0.02% | 478 |
|
|
2021
Q4 | $305K | Buy |
604
+12
| +2% | +$6.06K | 0.02% | 435 |
|
|
2021
Q3 | $364K | Sell |
592
-3
| -0.5% | -$1.85K | 0.03% | 404 |
|
|
2021
Q2 | $408K | Sell |
595
-39
| -6% | -$26.7K | 0.03% | 359 |
|
|
2021
Q1 | $354K | Buy |
634
+126
| +25% | +$70.4K | 0.03% | 367 |
|
|
2020
Q4 | $250K | Buy |
508
+16
| +3% | +$7.87K | 0.02% | 396 |
|
|
2020
Q3 | $218K | Buy |
+492
| New | +$218K | 0.03% | 374 |
|